Tyrosine-kinase inhibitors (TKI) in metastatic kidney cancer (mKC) treatment.

被引：0
|
作者：
Vladimirova, Liubov Yu [1 ]
Kit, Oleg Ivanovich [1 ]
Popova, Irina L. [1 ]
Abramova, Natalya A. [1 ]
机构：
[1] Rostov Sci Res Inst Oncol, Rostov Na Donu, Russia
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期
关键词：
D O I：
10.1200/jco.2014.32.15_suppl.e15546
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15546
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Stopping treatment with tyrosine-kinase inhibitors
    Rea, D.
    Mahon, F. -X.
    ONCOLOGIE, 2012, 14 (10-11) : 606 - 608
  • [2] NATURAL TYROSINE-KINASE INHIBITORS
    LECAM, A
    PATHOLOGIE BIOLOGIE, 1991, 39 (08): : 796 - 800
  • [3] Chemotherapy and tyrosine-kinase inhibitors for medullary thyroid cancer
    Hadoux, Julien
    Schlumberger, Martin
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 335 - 347
  • [4] A Tyrosine-kinase inhibitors (TKIs) treatment in sporadic Medullary Thyroid Cancer in a boy
    Cau, Ana Carolina Arias
    Cosentini, Maria Luz
    Alderete, Silvana
    Viso, Rene
    Gazek, Natalia
    Ayarzabal, Victor Hugo
    Dujovne, Noelia Vanesa
    HORMONE RESEARCH IN PAEDIATRICS, 2023, 96 (SUPPL 2): : 137 - 138
  • [5] Emerging tyrosine kinase inhibitors for the treatment of metastatic colorectal cancer
    Matos, Ignacio
    Elez, Elena
    Capdevila, Jaume
    Tabernero, Josep
    EXPERT OPINION ON EMERGING DRUGS, 2016, 21 (03) : 267 - 282
  • [6] Significance of Tyrosine Kinase Inhibitors in the Treatment of Metastatic Breast Cancer
    Mundhenke, Christoph
    Strauss, Alexander
    Schem, Christian
    BREAST CARE, 2009, 4 (06) : 373 - 378
  • [7] The molecular basis for RET tyrosine-kinase inhibitors in thyroid cancer
    De Falco, Valentina
    Carlomagno, Francesca
    Li, Hong-yu
    Santoro, Massimo
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2017, 31 (03) : 307 - 318
  • [8] Characterization of acquired receptor tyrosine-kinase fusions as mechanisms of resistance to EGFR tyrosine-kinase inhibitors
    Xu, Haiyuan
    Shen, Jinge
    Xiang, Jianxing
    Li, Haiyan
    Li, Bing
    Zhang, Tengfei
    Zhang, Lu
    Mao, Xinru
    Jian, Hong
    Shu, Yongqian
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6343 - 6350
  • [9] Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancer
    Gadd, Monique
    Pranavan, Ganesalingam
    Malik, Laeeq
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2019, 15 : 171 - 171
  • [10] Association between tyrosine-kinase inhibitor induced hypertension and treatment outcomes in metastatic renal cancer
    Gadd, Monique
    Pranavan, Ganes
    Malik, Laeeq
    CANCER REPORTS, 2020, 3 (05)
12345